Mouse Model of Cat Allergic Rhinitis and Intranasal Liposome-Adjuvanted Refined Fel d 1 Vaccine.
Cats (Felis domesticus) are rich source of airborne allergens that prevailed in the environment and sensitized a number of people to allergy. In this study, a mouse model of allergic rhinitis caused by the cat allergens was developed for the first time and the model was used for testing therapeutic...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2016-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4783078?pdf=render |
| _version_ | 1811282034106040320 |
|---|---|
| author | Natt Tasaniyananda Urai Chaisri Anchalee Tungtrongchitr Wanpen Chaicumpa Nitat Sookrung |
| author_facet | Natt Tasaniyananda Urai Chaisri Anchalee Tungtrongchitr Wanpen Chaicumpa Nitat Sookrung |
| author_sort | Natt Tasaniyananda |
| collection | DOAJ |
| description | Cats (Felis domesticus) are rich source of airborne allergens that prevailed in the environment and sensitized a number of people to allergy. In this study, a mouse model of allergic rhinitis caused by the cat allergens was developed for the first time and the model was used for testing therapeutic efficacy of a novel intranasal liposome-entrapped vaccines made of native Fel d 1 (major cat allergen) in comparison with the vaccine made of crude cat hair extract (cCE). BALB/c mice were sensitized with cCE mixed with alum intraperitoneally and intranasally. The allergic mice were treated with eight doses of either liposome (L)-entrapped native Fel d 1 (L-nFD1), L-cCE), or placebo on every alternate day. Vaccine efficacy evaluation was performed one day after provoking the treated mice with aerosolic cCE. All allergenized mice developed histological features of allergic rhinitis with rises of serum specific-IgE and Th2 cytokine gene expression. Serum IgE and intranasal mucus production of allergic mice reduced significantly after vaccination in comparison with the placebo mice. The vaccines also caused a shift of the Th2 response (reduction of Th2 cytokine expressions) towards the non-pathogenic responses: Th1 (down-regulation of the Th1 suppressive cytokine gene, IL-35) and Treg (up-regulation of IL-10 and TGF-β). In conclusions, a mouse model of allergic rhinitis to cat allergens was successfully developed. The intranasal, liposome-adjuvanted vaccines, especially the refined single allergen formulation, assuaged the allergic manifestations in the modeled mice. The prototype vaccine is worthwhile testing further for clinical use in the pet allergic patients. |
| first_indexed | 2024-04-13T01:44:21Z |
| format | Article |
| id | doaj.art-8e3d6ee238174586accb7b5e385e7683 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-13T01:44:21Z |
| publishDate | 2016-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-8e3d6ee238174586accb7b5e385e76832022-12-22T03:08:05ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01113e015046310.1371/journal.pone.0150463Mouse Model of Cat Allergic Rhinitis and Intranasal Liposome-Adjuvanted Refined Fel d 1 Vaccine.Natt TasaniyanandaUrai ChaisriAnchalee TungtrongchitrWanpen ChaicumpaNitat SookrungCats (Felis domesticus) are rich source of airborne allergens that prevailed in the environment and sensitized a number of people to allergy. In this study, a mouse model of allergic rhinitis caused by the cat allergens was developed for the first time and the model was used for testing therapeutic efficacy of a novel intranasal liposome-entrapped vaccines made of native Fel d 1 (major cat allergen) in comparison with the vaccine made of crude cat hair extract (cCE). BALB/c mice were sensitized with cCE mixed with alum intraperitoneally and intranasally. The allergic mice were treated with eight doses of either liposome (L)-entrapped native Fel d 1 (L-nFD1), L-cCE), or placebo on every alternate day. Vaccine efficacy evaluation was performed one day after provoking the treated mice with aerosolic cCE. All allergenized mice developed histological features of allergic rhinitis with rises of serum specific-IgE and Th2 cytokine gene expression. Serum IgE and intranasal mucus production of allergic mice reduced significantly after vaccination in comparison with the placebo mice. The vaccines also caused a shift of the Th2 response (reduction of Th2 cytokine expressions) towards the non-pathogenic responses: Th1 (down-regulation of the Th1 suppressive cytokine gene, IL-35) and Treg (up-regulation of IL-10 and TGF-β). In conclusions, a mouse model of allergic rhinitis to cat allergens was successfully developed. The intranasal, liposome-adjuvanted vaccines, especially the refined single allergen formulation, assuaged the allergic manifestations in the modeled mice. The prototype vaccine is worthwhile testing further for clinical use in the pet allergic patients.http://europepmc.org/articles/PMC4783078?pdf=render |
| spellingShingle | Natt Tasaniyananda Urai Chaisri Anchalee Tungtrongchitr Wanpen Chaicumpa Nitat Sookrung Mouse Model of Cat Allergic Rhinitis and Intranasal Liposome-Adjuvanted Refined Fel d 1 Vaccine. PLoS ONE |
| title | Mouse Model of Cat Allergic Rhinitis and Intranasal Liposome-Adjuvanted Refined Fel d 1 Vaccine. |
| title_full | Mouse Model of Cat Allergic Rhinitis and Intranasal Liposome-Adjuvanted Refined Fel d 1 Vaccine. |
| title_fullStr | Mouse Model of Cat Allergic Rhinitis and Intranasal Liposome-Adjuvanted Refined Fel d 1 Vaccine. |
| title_full_unstemmed | Mouse Model of Cat Allergic Rhinitis and Intranasal Liposome-Adjuvanted Refined Fel d 1 Vaccine. |
| title_short | Mouse Model of Cat Allergic Rhinitis and Intranasal Liposome-Adjuvanted Refined Fel d 1 Vaccine. |
| title_sort | mouse model of cat allergic rhinitis and intranasal liposome adjuvanted refined fel d 1 vaccine |
| url | http://europepmc.org/articles/PMC4783078?pdf=render |
| work_keys_str_mv | AT natttasaniyananda mousemodelofcatallergicrhinitisandintranasalliposomeadjuvantedrefinedfeld1vaccine AT uraichaisri mousemodelofcatallergicrhinitisandintranasalliposomeadjuvantedrefinedfeld1vaccine AT anchaleetungtrongchitr mousemodelofcatallergicrhinitisandintranasalliposomeadjuvantedrefinedfeld1vaccine AT wanpenchaicumpa mousemodelofcatallergicrhinitisandintranasalliposomeadjuvantedrefinedfeld1vaccine AT nitatsookrung mousemodelofcatallergicrhinitisandintranasalliposomeadjuvantedrefinedfeld1vaccine |